Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serpin family A member 13, pseudogene (SERPINA13P)
- Target
- SERPINA13P
- Molecular classification
- Pseudogene, Serpin family (clade A), Protease inhibitor (family context, not functional for this pseudogene)
01
Overview
Serpin family A member 13, pseudogene (SERPINA13P) is designated as a pseudogene in the human genome and is a non-functional member of the serpin superfamily, specifically derived from clade A, typically associated with serine protease inhibition. Owing to sequence mutations, insertions, or deletions accumulated over evolutionary time, SERPINA13P is not capable of encoding a functional protein. Unlike its functional serpin family relatives (such as alpha-1 antitrypsin), the SERPINA13P locus is transcriptionally silent or yields non-functional RNA. As a result, it is not considered a therapeutic target and has no established biological or disease associations. It serves primarily as a genomic "fossil" or relic reflecting the duplication and inactivation of its parental gene family.
- Other names
- SERPINA13UNQ6121Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 13, pseudogenePutative Serpin A13Protease inhibitor
02
Mechanism of action
Not applicable (no known active protein, not a drug target)
03
Biological functions
None knowndoes not have protein-coding activity (predicted to lack functionality)
04
Disease associations
None specificno direct disease involvement confirmed. Rarely, pseudogenes may act through regulatory RNAs, but there is no evidence for SERPINA13P in this regard
Beyond the preview
Go deeper on Serpin family A member 13, pseudogene (SERPINA13P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Serpin family A member 13, pseudogene (SERPINA13P).